DanCann Pharma A/S has pressed the start button in BIOTECH PHARM1
COPENHAGEN, Denmark, 22 April 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby announce that following pre-selective operations around the Company's genetics in BIOTECH PHARM1 (“the Facility”), the Company today begins its first real operations and first cycles in its new Facility.The Danish biopharmaceutical manufacturer DanCann Pharma has just announced that the first phase in the establishment of the company's high-tech production Facility, the BIOTECH PHARM1, in Ansager has now been completed - and that the Facility has been put into operation. The